NYC DOHMH Advisory #37: All Point-of-Care COVID-19 Test Results Must be Reported Electronically
September 18, 2020
The New York City Department of Health and Mental Hygiene (DOHMH) has issued a health advisory with information that pertains to point-of-care (POC) SARS-CoV-2 tests performed at sites that hold a Clinical Laboratory Improvement Amendment (CLIA) Certificate of Waiver where patient care is provided.
Facilities that perform point-of-care SARS-CoV-2 testing (including nucleic acid amplification [NAA], antigen, and antibody tests) are required to report all results (e.g., positive, negative, and indeterminate) via the New York State (NYS) Electronic Clinical Laboratory Reporting System (ECLRS).
Providers must inquire regarding patients’ school, employment, and local address information when performing COVID-19 tests and include such information in the ECLRS report or lab requisition form.
NYS now requires providers licensed by the NYS Department of Health Physician Office Laboratory Evaluation Program to report influenza test results via ECLRS.
Antigen-based SARS-CoV-2 diagnostic tests have limited sensitivity. Negative antigen-based test results may require confirmation with a laboratory-based NAA test.
Please refer to Health Advisory #37 for additional information.